American Journal of Cardiovascular Drugs

Show Articles
Journal Properties
  • Country
    United Kingdom
  • Language
    English
  • Number of Articles
    1,214
  • Abbreviation
    Am J Cardiovasc Drugs
  • ISSN
    1175-3277
  • e-ISSN
    1179-187X
  • Main Publisher
    Springer Nature
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Journal Properties
  • Medicine
    Internal medicine
    Specialties of internal medicine
    Diseases of the circulatory (Cardiovascular) system
    Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
The American Journal of Cardiovascular Drugs is a peer-reviewed publication concentrating on pharmacological interventions for cardiovascular health. This journal offers essential insights into drug-based treatments for heart conditions, from discovery to clinical use. Researchers and clinicians benefit from access to the newest developments in cardiovascular pharmacotherapy. Focusing on cardiovascular pharmacology, the journal covers clinical trials, drug mechanisms, and outcomes related to various heart conditions. Key topics include antiarrhythmics, antihypertensives, and antithrombotic agents. Indexed in key databases and targeting cardiologists, cardiovascular pharmacologists, and other healthcare professionals, the journal is a crucial resource for the latest drug therapies. By publishing in this journal, you contribute to the enhanced comprehension and management of cardiovascular diseases. Investigate the submission requirements and be part of an ongoing discussion that shapes the future of cardiovascular care. The journal seeks to further improve the well-being and longevity of patients affected by cardiac conditions.